These cases were particularly intriguing because of the high rate of myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) in affected individuals, and demonstrated a key link between RUNX1 haploinsufficiency and predisposition to malignant hematopoiesis (Owen et al, 2008). This evidence concerns the gene RUNX1 and myelodysplastic syndrome.